Table 5 Results of meta-analysis of the secondary outcome
Outcome measures | Number of studies | Patients (HCR/CABG) | I2 (%) | Analysis model | Statistics method | OR/WMD | 95% CI | p value |
|---|---|---|---|---|---|---|---|---|
AF | 5 | 468/1274 | 0 | Fixed | M-H | 0.93 | 0.70,1.23 | 0.60 |
Renal Failure | 5 | 372/1191 | 0 | Fixed | M-H | 0.64 | 0.32,1.27 | 0.20 |
Intubation Time | 3 | 132/160 | 93 | Random | IV | −9.95 | −18.58,-1.31 | 0.02 |
LOS in ICU | 6 | 322/805 | 85 | Random | IV | −17.47 | −31.01,-3.93 | 0.01 |
LOS in hospital | 5 | 304/775 | 82 | Random | IV | −1.77 | −3.07,-0.46 | 0.008 |
Red Blood Cells Transfusion | 3 | 53/83 | 0 | Fixed | IV | −1.25 | −1.62,-0.88 | P<0.00001 |